The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study-Reference-Cited by-同舟云学术

The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study

Published:2015-12 Issue: Volume:81 Page:675-682
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

van der Hoorn Mariëlle M.C.,Tett Susan E.,de Vries Oscar J.,Dobson Annette J.,Peeters G.M.E.E. (Geeske)

Funder

Australian Government Department of Health

Australian National Health and Medical Research Council

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference49 articles.

1. Prescribing of anti-osteoporotic therapies following the use of proton pump inhibitors in general practice;McGowan;Pharmacoepidemiol. Drug Saf.,2010

2. Use of proton pump inhibitors and risk of osteoporosis-related fractures;Targownik;CMAJ,2008

3. Overutilization of proton-pump inhibitors: what the clinician needs to know;Heidelbaugh;Ther. Adv. Gastroenterol.,2012

4. Differences in Utilisation of Gastroprotective Drugs Between 2001 and 2005 in Australia and Nova Scotia;Tett,2013

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Association Between Oral Bone Mineral Density–Reducing Medications and the Risk of 2-Year Implant-Related Complications Following Total Knee Arthroplasty;The Journal of Arthroplasty;2024-09

2. Drug-induced osteoporosis and mechanisms of bone tissue regeneration through trace elements;Journal of Trace Elements in Medicine and Biology;2024-07

3. Effect of long-term proton pump inhibitors on phosphocalcium metabolism and bone mineral density;Future Science OA;2024-04-17

4. Long-Term Use of Proton-Pump Inhibitors: Unravelling the Safety Puzzle;Cureus;2024-01-23

5. Potentially Inappropriate Gastrointestinal Medication for Patients with the Common Cold;Research in Clinical Pharmacy;2023-12-31